TN2010000038A1 - Organic compounds - Google Patents

Organic compounds

Info

Publication number: TN2010000038A1
Authority: TN; Tunisia
Prior art keywords: organic compounds; salt; compounds; phosphatidylinositol; solvate
Prior art date: 2007-07-26

Application number

TNP2010000038A

Other languages

English (en)

Inventor

Ian Bruce

Andrew Dunstan

Thomas Anthony Hunt

Catherine Howsham

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-26

Filing date

2010-01-22

Publication date

2011-09-26

2010-01-22 Application filed by Novartis Ag filed Critical Novartis Ag

2011-09-26 Publication of TN2010000038A1 publication Critical patent/TN2010000038A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Diabetes (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

TNP2010000038A 2007-07-26 2010-01-22 Organic compounds TN2010000038A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07113237		2007-07-26
PCT/EP2008/059748 WO2009013348A2 (fr)	2007-07-26	2008-07-24	Composés organiques

Publications (1)

Publication Number	Publication Date
TN2010000038A1 true TN2010000038A1 (en)	2011-09-26

Family

ID=38942282

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2010000038A TN2010000038A1 (en)	2007-07-26	2010-01-22	Organic compounds

Country Status (21)

Country	Link
EP (1)	EP2173722B1 (fr)
JP (1)	JP5485884B2 (fr)
KR (1)	KR20100025006A (fr)
CN (1)	CN101765591B (fr)
AR (1)	AR067869A1 (fr)
AU (1)	AU2008278966B2 (fr)
BR (1)	BRPI0813629A2 (fr)
CA (1)	CA2694275A1 (fr)
CL (1)	CL2008002185A1 (fr)
CO (1)	CO6290670A2 (fr)
CR (1)	CR11208A (fr)
EA (1)	EA201000104A1 (fr)
EC (1)	ECSP109900A (fr)
ES (1)	ES2394126T3 (fr)
MA (1)	MA31594B1 (fr)
MX (1)	MX2010001020A (fr)
PE (1)	PE20090880A1 (fr)
SV (1)	SV2010003464A (fr)
TN (1)	TN2010000038A1 (fr)
TW (1)	TW200909426A (fr)
WO (1)	WO2009013348A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8268834B2 (en) *	2008-03-19	2012-09-18	Novartis Ag	Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
GB0815947D0 (en) *	2008-09-02	2008-10-08	Univ Dundee	Compounds
JP2012521354A (ja)	2009-03-20	2012-09-13	アムジエン・インコーポレーテツド	Ｐｉ３キナーゼの阻害薬
UY32582A (es)	2009-04-28	2010-11-30	Amgen Inc	Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamífero
JP4967004B2 (ja) *	2009-09-14	2012-07-04	東京エレクトロン株式会社	レジスト塗布現像装置およびレジスト塗布現像方法
JP2017502092A (ja)	2014-01-14	2017-01-19	ミレニアムファーマシューティカルズ，インコーポレイテッドＭｉｌｌｅｎｎｉｕｍＰｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ．	ヘテロアリール及びその使用
AP2016009368A0 (en)	2014-01-14	2016-08-31	Millennium Pharm Inc	Heteroaryls and uses thereof
AU2014391605A1 (en)	2014-04-24	2016-10-27	Novartis Ag	Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
BR112016023967A2 (pt)	2014-04-24	2017-08-15	Novartis Ag	derivados de pirazina como inibidores de fosfatidilinositol 3-cinase
CA2945212A1 (fr)	2014-04-24	2015-10-29	Novartis Ag	Derives amines de pyrazine utilisables en tant qu'inhibiteurs de la phosphatidylinositol 3-kinase
EP3728230A1 (fr) *	2017-12-22	2020-10-28	Ravenna Pharmaceuticals, Inc.	Dérivés d'amine aryl-bipyridine utilisés en tant qu'inhibiteurs de la phosphatidylinositol phosphate kinase
CN112074505B (zh)	2018-03-08	2024-04-05	因赛特公司	作为PI3K-γ抑制剂的氨基吡嗪二醇化合物
WO2020010003A1 (fr)	2018-07-02	2020-01-09	Incyte Corporation	DÉRIVÉS D'AMINOPYRAZINE UTILISÉS EN TANT QU'INHIBITEURS DE PI3K-γ

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW520362B (en) *	1996-12-05	2003-02-11	Amgen Inc	Substituted pyrimidine compounds and pharmaceutical composition comprising same
WO2001062233A2 (fr) *	2000-02-25	2001-08-30	F. Hoffmann La Roche Ag	Modulateurs de recepteurs de l'adenosine
MY130778A (en) *	2001-02-09	2007-07-31	Vertex Pharma	Heterocyclic inhibitiors of erk2 and uses thereof
US20030208067A1 (en) *	2001-05-30	2003-11-06	Cao Sheldon Xiaodong	Inhibitors of protein kinase for the treatment of disease
AUPR688101A0 (en) *	2001-08-08	2001-08-30	Luminis Pty Limited	Protein domains and their ligands
WO2003030909A1 (fr) *	2001-09-25	2003-04-17	Bayer Pharmaceuticals Corporation	2- et 4-aminopyrimidines n-substituees par un noyau bicyclique utilisees comme inhibiteurs de kinases dans le traitement du cancer
TWI330183B (fr) *	2001-10-22	2010-09-11	Eisai R&D Man Co Ltd
AU2002950853A0 (en) *	2002-08-19	2002-09-12	Fujisawa Pharmaceutical Co., Ltd.	Aminopyrimidine compound and pharmaceutical use thereof
US7405221B2 (en) *	2002-09-27	2008-07-29	Merck & Co., Inc.	Substituted pyrimidines
AU2003295776B2 (en) *	2002-11-21	2011-05-12	Novartis Vaccines And Diagnostics, Inc.	2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
CN1735607B (zh) *	2002-11-21	2010-06-09	诺华疫苗和诊断公司	2,4,6-三取代的嘧啶作为磷脂酰肌醇(pi)3-激酶抑制剂及其在治疗癌症中的应用
MXPA05009063A (es) *	2003-02-26	2005-12-12	Sugen Inc	Compuestos de aminoheteroarilo como inhibidores de proteina cinasa.
SE0301010D0 (sv) *	2003-04-07	2003-04-07	Astrazeneca Ab	Novel compounds
WO2005005380A2 (fr) *	2003-06-30	2005-01-20	Merck & Co., Inc.	Derives de 17-acetamido-4-azasteroide en tant que modulateurs du recepteur d'androgene
ES2229928B1 (es) *	2003-10-02	2006-07-01	Almirall Prodesfarma, S.A.	Nuevos derivados de pirimidin-2-amina.
NZ553267A (en) *	2004-07-27	2010-09-30	Sgx Pharmaceuticals Inc	Pyrrolo-pyridine kinase modulators
SE0402735D0 (sv) *	2004-11-09	2004-11-09	Astrazeneca Ab	Novel compounds
EA200701930A1 (ru) *	2005-03-10	2008-02-28	Байер Фармасьютикалс Корпорейшн	Производные пиримидина для лечения гиперпролиферативных нарушений
WO2007111904A2 (fr) *	2006-03-22	2007-10-04	Vertex Pharmaceuticals Incorporated	Inhibiteurs de la c-met proteine kinase
GB0608820D0 (en) *	2006-05-04	2006-06-14	Piramed Ltd	Pharmaceutical compounds
GB0610242D0 (en) *	2006-05-23	2006-07-05	Novartis Ag	Organic compounds
MX2009000864A (es) *	2006-07-28	2009-02-03	Novartis Ag	Quinazolinas 2,4-sustituidas como inhibidores de cinasa de lipido.
WO2008025821A1 (fr) *	2006-08-30	2008-03-06	Cellzome Limited	Dérivés de triazole en tant qu'inhibiteurs de kinase
AR067354A1 (es) *	2007-06-29	2009-10-07	Sunesis Pharmaceuticals Inc	Compuestos utiles como inhibidores de la raf quinasa

2008
- 2008-07-24 KR KR1020107001657A patent/KR20100025006A/ko not_active Abandoned
- 2008-07-24 WO PCT/EP2008/059748 patent/WO2009013348A2/fr not_active Ceased
- 2008-07-24 JP JP2010517408A patent/JP5485884B2/ja active Active
- 2008-07-24 EP EP08775347A patent/EP2173722B1/fr active Active
- 2008-07-24 CN CN2008801002897A patent/CN101765591B/zh active Active
- 2008-07-24 CA CA2694275A patent/CA2694275A1/fr not_active Abandoned
- 2008-07-24 AU AU2008278966A patent/AU2008278966B2/en not_active Expired - Fee Related
- 2008-07-24 PE PE2008001259A patent/PE20090880A1/es not_active Application Discontinuation
- 2008-07-24 EA EA201000104A patent/EA201000104A1/ru unknown
- 2008-07-24 ES ES08775347T patent/ES2394126T3/es active Active
- 2008-07-24 MX MX2010001020A patent/MX2010001020A/es not_active Application Discontinuation
- 2008-07-24 BR BRPI0813629A patent/BRPI0813629A2/pt not_active IP Right Cessation
- 2008-07-25 TW TW097128507A patent/TW200909426A/zh unknown
- 2008-07-25 CL CL2008002185A patent/CL2008002185A1/es unknown
- 2008-07-28 AR ARP080103260A patent/AR067869A1/es not_active Application Discontinuation
2010
- 2010-01-08 CR CR11208A patent/CR11208A/es not_active Application Discontinuation
- 2010-01-22 TN TNP2010000038A patent/TN2010000038A1/fr unknown
- 2010-01-25 CO CO10007032A patent/CO6290670A2/es not_active Application Discontinuation
- 2010-01-26 SV SV2010003464A patent/SV2010003464A/es not_active Application Discontinuation
- 2010-01-26 EC EC2010009900A patent/ECSP109900A/es unknown
- 2010-02-05 MA MA32591A patent/MA31594B1/fr unknown

Also Published As

Publication number	Publication date
JP5485884B2 (ja)	2014-05-07
WO2009013348A3 (fr)	2009-07-23
WO2009013348A2 (fr)	2009-01-29
BRPI0813629A2 (pt)	2018-07-10
EA201000104A1 (ru)	2010-08-30
CN101765591A (zh)	2010-06-30
MX2010001020A (es)	2010-03-01
CN101765591B (zh)	2013-11-27
AU2008278966A1 (en)	2009-01-29
CA2694275A1 (fr)	2009-01-29
KR20100025006A (ko)	2010-03-08
ECSP109900A (es)	2010-02-26
EP2173722B1 (fr)	2012-08-29
SV2010003464A (es)	2010-05-21
PE20090880A1 (es)	2009-08-06
JP2010534634A (ja)	2010-11-11
AU2008278966B2 (en)	2012-02-23
AR067869A1 (es)	2009-10-28
CO6290670A2 (es)	2011-06-20
CL2008002185A1 (es)	2009-02-20
CR11208A (es)	2010-02-12
TW200909426A (en)	2009-03-01
EP2173722A2 (fr)	2010-04-14
MA31594B1 (fr)	2010-08-02
ES2394126T3 (es)	2013-01-22

Publication	Publication Date	Title
TN2010000038A1 (en)	2011-09-26	Organic compounds
TN2011000053A1 (en)	2012-09-05	Organic compounds
TW201000473A (en)	2010-01-01	Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
TN2010000293A1 (en)	2011-11-11	Thiazole derivatives used as pi 3 kinase inhibitors
EA201001669A1 (ru)	2011-06-30	Замещенные пиримидин-5-карбоксамиды 281
MX2010008460A (es)	2010-08-30	Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular.
MY149512A (en)	2013-09-13	Pyrazolylaminopyridine derivatives useful as kinase inhibitors
MX2012004089A (es)	2012-08-23	Inhibidores de hsp90.
WO2009155121A3 (fr)	2010-02-18	Inhibiteurs de la pi3 kinase
TN2009000049A1 (en)	2010-08-19	A pyrrolopyrazin as syk-kinase inhibitor
GEP20146125B (en)	2014-07-25	Aminopyrimidines as syk inhibitors
SG179418A1 (en)	2012-04-27	Inhibitors of the hedgehog pathway
MX2010006799A (es)	2010-10-05	Benzofuropirimidinonas como inhibidores de la proteina cinasa.
GEP20146146B (en)	2014-08-25	Pyrrolopyrimidine compounds as inhibitors of cdk4/6
JO2848B1 (en)	2014-09-15	Organic compounds
MX2010004493A (es)	2010-06-11	Compuestos de tropano.
TW200728307A (en)	2007-08-01	Novel spirochromanone derivatives
TW200833663A (en)	2008-08-16	Therapeutic agents
MX2009003081A (es)	2009-04-01	Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas.
WO2009080705A3 (fr)	2009-09-24	Composés organiques
MX2008016358A (es)	2009-01-16	Derivados de tiazolil-urea como inhibidores de cinasa de fosfatidil-inositol-3.
MX2010006108A (es)	2010-06-25	Inhibidores de estearoil-coa-desaturasa.
MX2012000177A (es)	2012-02-28	2-carboxamida-cicloamino-ureas sustituidas.
MX2008002061A (es)	2008-04-16	Derivados de tiazolil piperidina utiles como moduladores del receptor h3.
DE602004008959D1 (de)	2007-10-25	Benzoäbüä1,4üdioxepinderivate